• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Infinity Pharmaceuticals, Inc. (INFI)

    -NasdaqGS
    13.98 Mar 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:13.98
    Open:N/A
    Bid:12.93 x 400
    Ask:14.75 x 1000
    1y Target Est:19.11
    Beta:2.21
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:N/A - N/A
    52wk Range:8.40 - 18.25
    Volume:0
    Avg Vol (3m):733,239
    Market Cap:683.90M
    P/E (ttm):N/A
    EPS (ttm):-0.36
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INFI

    Comparison

    Symbol% ChgMkt Cap
    INFI 0.00%683.90M
    BMY106.59B
    PFE213.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.14
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.45
    Quarterly EPS Est (Mar-15) :-1.68
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-1.35

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Infinity Pharmaceuticals, Inc., a drug discovery and development company, discovers, develops, and delivers medicines to patients with difficult-to-treat diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback